VIEMED HEALTHCARE, INC. Net Income
VIEMED HEALTHCARE, INC. (VMD) reported Net Income of $2.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $2.76M, a 12.45% decline year-over-year.
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was $2.58M, a 1.64% decline year-over-year.
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was $6.11M, a 37.16% increase year-over-year.
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was $3.51M, a 9.41% decline year-over-year.
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for fiscal 2021 was $9.13M, a 71.06% decline from fiscal 2020.
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for fiscal 2020 was $31.53M, a 269.85% increase from fiscal 2019.
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for fiscal 2019 was $8.53M, a 10.34% decline from fiscal 2018.
- VIEMED HEALTHCARE, INC. net income (loss) attributable to parent for fiscal 2018 was $9.51M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.76M 10-Q · filed 2026-08-03 | $5.35M 10-Q · filed 2026-08-03 | $11.45M derived: sum of 3 quarters · filed 2026-08-03 | $14.96M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $2.58M 10-Q · filed 2026-05-05 | $8.69M derived: sum of 2 quarters · filed 2026-05-05 | $12.20M derived: sum of 3 quarters · filed 2026-05-05 | $15.36M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $6.11M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $9.62M derived: sum of 2 quarters · filed 2026-04-22 | $12.78M derived: sum of 3 quarters · filed 2026-08-03 | $15.40M DEF 14A · filed 2026-04-22 | $14.93M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $3.51M 10-Q · filed 2025-11-05 | $6.67M derived: sum of 2 quarters · filed 2026-08-03 | $9.29M 10-Q · filed 2025-11-05 | $13.75M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $3.16M 10-Q · filed 2026-08-03 | $5.78M 10-Q · filed 2026-08-03 | $10.23M derived: sum of 3 quarters · filed 2026-08-03 | $14.11M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $2.63M 10-Q · filed 2026-05-05 | $7.08M derived: sum of 2 quarters · filed 2026-05-05 | $10.95M derived: sum of 3 quarters · filed 2026-05-05 | $12.42M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $4.45M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $8.33M derived: sum of 2 quarters · filed 2026-04-22 | $9.80M derived: sum of 3 quarters · filed 2026-04-22 | $11.40M DEF 14A · filed 2026-04-22 | $11.27M 10-K · filed 2025-03-10 | |||
| 2024-09-30 | $3.88M 10-Q · filed 2025-11-05 | $5.35M derived: sum of 2 quarters · filed 2025-11-05 | $6.95M 10-Q · filed 2025-11-05 | $10.38M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-06-30 | $1.47M 10-Q · filed 2025-08-06 | $3.07M 10-Q · filed 2025-08-06 | $6.50M derived: sum of 3 quarters · filed 2026-04-22 | $9.42M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2024-03-31 | $1.60M 10-Q · filed 2025-05-07 | $5.04M derived: sum of 2 quarters · filed 2026-04-22 | $7.96M derived: sum of 3 quarters · filed 2026-04-22 | $10.29M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2023-12-31 | $3.43M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $6.35M derived: sum of 2 quarters · filed 2026-04-22 | $8.68M derived: sum of 3 quarters · filed 2026-04-22 | $10.20M DEF 14A · filed 2026-04-22 | $10.24M 10-K · filed 2024-03-06 | |||
| 2023-09-30 | $2.92M 10-Q · filed 2024-11-06 | $5.25M derived: sum of 2 quarters · filed 2024-11-06 | $6.77M 10-Q · filed 2024-11-06 | $9.18M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2023-06-30 | $2.33M 10-Q · filed 2024-08-07 | $3.85M 10-Q · filed 2024-08-07 | $6.26M derived: sum of 3 quarters · filed 2026-04-22 | $7.32M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2023-03-31 | $1.52M 10-Q · filed 2024-05-06 | $3.93M derived: sum of 2 quarters · filed 2026-04-22 | $4.99M derived: sum of 3 quarters · filed 2026-04-22 | $5.96M derived: sum of 4 quarters · filed 2026-04-22 | ||||
| 2022-12-31 | $2.42M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | $3.47M derived: sum of 2 quarters · filed 2026-04-22 | $4.44M derived: sum of 3 quarters · filed 2026-04-22 | $6.20M DEF 14A · filed 2026-04-22 | $6.22M 10-K · filed 2023-03-02 | |||
| 2022-09-30 | $1.05M 10-Q · filed 2023-11-01 | $2.02M derived: sum of 2 quarters · filed 2023-11-01 | $3.78M 10-Q · filed 2023-11-01 | $7.87M derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-06-30 | $967.00K 10-Q · filed 2023-11-01 | $2.73M 10-Q · filed 2023-08-09 | $6.82M derived: sum of 3 quarters · filed 2023-11-01 | $8.61M derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-03-31 | $1.76M 10-Q · filed 2023-11-01 | $5.85M derived: sum of 2 quarters · filed 2023-11-01 | $7.64M derived: sum of 3 quarters · filed 2023-11-01 | $9.20M derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2021-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $5.88M derived: sum of 2 quarters · filed 2023-03-02 | $7.44M derived: sum of 3 quarters · filed 2023-03-02 | $9.13M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $1.79M 10-Q · filed 2022-11-01 | $3.35M derived: sum of 2 quarters · filed 2022-11-01 | $5.04M 10-Q · filed 2022-11-01 | $10.11M derived: sum of 4 quarters · filed 2022-11-01 | ||||
| 2021-06-30 | $1.57M 10-Q · filed 2022-11-01 | $3.25M 10-Q · filed 2022-08-02 | $8.32M derived: sum of 3 quarters · filed 2022-11-01 | $11.13M derived: sum of 4 quarters · filed 2022-11-01 | ||||
| 2021-03-31 | $1.68M 10-Q · filed 2022-11-01 | $6.75M derived: sum of 2 quarters · filed 2022-11-01 | $9.56M derived: sum of 3 quarters · filed 2022-11-01 | $28.97M derived: sum of 4 quarters · filed 2022-11-01 | ||||
| 2020-12-31 | $5.07M 10-K · filed 2021-03-03 | $7.88M derived: sum of 2 quarters · filed 2021-11-02 | $27.29M derived: sum of 3 quarters · filed 2021-11-02 | $31.53M 10-K · filed 2022-03-07 | ||||
| 2020-09-30 | $2.80M 10-Q · filed 2021-11-02 | $22.22M derived: sum of 2 quarters · filed 2021-11-02 | $26.46M 10-Q · filed 2021-11-02 | $28.85M derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | $19.41M 10-Q · filed 2021-11-02 | $23.66M 10-Q · filed 2021-08-03 | $26.04M derived: sum of 3 quarters · filed 2021-11-02 | $28.90M derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-03-31 | $4.24M 10-Q · filed 2021-11-02 | $6.63M derived: sum of 2 quarters · filed 2021-11-02 | $9.48M derived: sum of 3 quarters · filed 2021-11-02 | $10.81M derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2019-12-31 | $2.39M 10-K · filed 2021-03-03 | $5.24M derived: sum of 2 quarters · filed 2021-03-03 | $6.57M derived: sum of 3 quarters · filed 2021-03-03 | $8.53M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | $2.85M 10-K · filed 2021-03-03 | $2.96M 10-Q · filed 2019-11-05 | $4.18M derived: sum of 2 quarters · filed 2021-03-03 | $6.14M 10-Q · filed 2020-11-04 | $6.93M 10-Q · filed 2019-11-05 | $9.11M derived: sum of 4 quarters · filed 2021-03-03 | ||
| 2019-06-30 | $1.33M 10-K · filed 2021-03-03 | $1.82M 10-Q · filed 2019-08-09 | $3.28M 10-Q · filed 2020-08-04 | $3.97M 10-Q · filed 2019-08-09 | $6.25M derived: sum of 3 quarters · filed 2021-03-03 | $8.47M derived: sum of 4 quarters · filed 2021-03-03 | ||
| 2019-03-31 | $1.96M 10-K · filed 2021-03-03 | $2.15M 10-Q · filed 2019-08-09 | $4.93M derived: sum of 2 quarters · filed 2021-03-03 | $7.14M derived: sum of 3 quarters · filed 2021-03-03 | $9.24M derived: sum of 4 quarters · filed 2021-03-03 | |||
| 2018-12-31 | $2.97M 10-K · filed 2020-03-04 | $5.19M derived: sum of 2 quarters · filed 2020-03-04 | $7.29M derived: sum of 3 quarters · filed 2020-03-04 | $9.51M 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | $2.22M 10-K · filed 2020-03-04 | $2.42M 10-Q · filed 2019-11-05 | $4.32M derived: sum of 2 quarters · filed 2020-03-04 | $7.13M 10-Q · filed 2019-11-05 | ||||
| 2018-06-30 | $2.10M 10-K · filed 2020-03-04 | $2.37M 10-Q · filed 2019-08-09 | $4.71M 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | $2.22M 10-K · filed 2020-03-04 | $2.34M 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |